BioCentury
ARTICLE | Company News

Athena Pharmaceutiques, Veloxis Pharmaceuticals sales and marketing update

January 2, 2012 8:00 AM UTC

Veloxis granted Athena exclusive rights in undisclosed emerging regions to develop and commercialize AtorFen. Athena will fund manufacturing of the product in India and form partnerships with third pa...